Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenLight Biosciences is a life sciences company focused on the development and production of RNA-based solutions for human health and agriculture. The company utilizes a proprietary cell-free platform that enables the scalable and cost-effective production of high-quality RNA, addressing historical challenges in mRNA vaccine accessibility and targeted pest management. GreenLight's healthcare portfolio includes mRNA vaccine candidates for infectious diseases like COVID-19, shingles, and seasonal influenza, while its agricultural segment offers innovative dsRNA products for crop protection. Following its acquisition in 2023, the company operates as a private entity, continuing to advance its RNA synthesis technology across multiple therapeutic and environmental applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenEvolution.